AccountingForlove t1_j3ir8d0 wrote on January 8, 2023 at 9:27 PM Reply to A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii And yet prophylaxis was never the intended use of HcQ. Permalink 2
AccountingForlove t1_j3ir8d0 wrote
Reply to A randomized double-blind controlled trial found post-exposure prophylaxis with hydroxychloroquine (HCQ) was not advantageous for the prevention of COVID-19 in asymptomatic individuals with high risk for SARS-CoV-2 infection. The incidence of COVID-19 was similar in both the HCQ group and control. by glawgii
And yet prophylaxis was never the intended use of HcQ.